Banco Santander, S.A. Boston Scientific Corp Transaction History

Banco Santander, S.A.

$8.47 Billion
Q3 2024

A detailed history of Banco Santander, S.A. transactions in Boston Scientific Corp stock. As of the latest transaction made, Banco Santander, S.A. holds 28,124 shares of BSX stock, worth $2.54 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

28,124

Previous 28,587 1.62%

Holding current value

$2.54 Million

Previous $2.2 Million 7.04%

% of portfolio

0.03%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$72.96 - $84.0 $33,780 - $38,892	-463 Reduced 1.62%	28,124 $2.36 Million
Q2 2024 Jul 29, 2024	SELL	$67.33 - $77.71 $48,073 - $55,484	-714 Reduced 2.44%	28,587 $2.2 Million
Q1 2024 May 10, 2024	BUY	$57.6 - $68.62 $2,649 - $3,156	46 Added 0.16%	29,301 $2.01 Million
Q4 2023 Feb 09, 2024	BUY	$48.64 - $57.81 $122,816 - $145,970	2,525 Added 9.45%	29,255 $1.69 Million
Q3 2023 Nov 08, 2023	SELL	$50.19 - $54.68 $9.21 Million - $10 Million	-183,602 Reduced 87.29%	26,730 $1.41 Million
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $9.28 Million - $10.2 Million	186,641 Added 787.81%	210,332 $11.4 Million
Q1 2023 May 10, 2023	BUY	$45.09 - $50.03 $459,061 - $509,355	10,181 Added 75.36%	23,691 $1.19 Million
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $36,434 - $43,489	-921 Reduced 6.38%	13,510 $625,000
Q3 2022 Nov 08, 2022	SELL	$36.71 - $109.66 $7,011 - $20,945	-191 Reduced 1.31%	14,431 $559,000
Q2 2022 Jul 28, 2022	SELL	$35.24 - $47.1 $420,025 - $561,384	-11,919 Reduced 44.91%	14,622 $545,000
Q1 2022 May 09, 2022	SELL	$40.9 - $45.1 $954,646 - $1.05 Million	-23,341 Reduced 46.79%	26,541 $1.18 Million
Q4 2021 Feb 09, 2022	BUY	$38.07 - $44.87 $1.19 Million - $1.4 Million	31,240 Added 167.58%	49,882 $2.12 Million
Q3 2021 Nov 08, 2021	BUY	$41.23 - $45.88 $58,546 - $65,149	1,420 Added 8.25%	18,642 $809,000
Q2 2021 Jul 29, 2021	SELL	$38.58 - $44.24 $33,873 - $38,842	-878 Reduced 4.85%	17,222 $736,000
Q1 2021 May 10, 2021	SELL	$35.27 - $39.67 $134,801 - $151,618	-3,822 Reduced 17.43%	18,100 $700,000
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $56,951 - $72,104	1,718 Added 8.5%	21,922 $788,000
Q3 2020 Nov 09, 2020	SELL	$34.44 - $42.23 $144,579 - $177,281	-4,198 Reduced 17.2%	20,204 $772,000
Q2 2020 Aug 05, 2020	SELL	$30.19 - $39.11 $43,684 - $56,592	-1,447 Reduced 5.6%	24,402 $857,000
Q1 2020 May 11, 2020	SELL	$25.83 - $45.71 $140,308 - $248,296	-5,432 Reduced 17.37%	25,849 $844,000
Q4 2019 Feb 07, 2020	SELL	$37.87 - $45.37 $52,260 - $62,610	-1,380 Reduced 4.23%	31,281 $1.41 Million
Q3 2019 Nov 06, 2019	SELL	$40.31 - $43.45 $91,221 - $98,327	-2,263 Reduced 6.48%	32,661 $1.33 Million
Q2 2019 Aug 07, 2019	SELL	$34.91 - $42.98 $8.9 Million - $11 Million	-254,831 Reduced 87.95%	34,924 $1.5 Million
Q1 2019 May 13, 2019	BUY	$32.91 - $40.75 $3.88 Million - $4.81 Million	117,972 Added 68.68%	289,755 $11.1 Million
Q4 2018 Feb 12, 2019	SELL	$31.73 - $39.04 $78,975 - $97,170	-2,489 Reduced 1.43%	171,783 $6.07 Million
Q3 2018 Nov 13, 2018	SELL	$32.83 - $38.63 $1.14 Million - $1.34 Million	-34,640 Reduced 16.58%	174,272 $6.71 Million
Q2 2018 Aug 14, 2018	SELL	$26.84 - $34.32 $2.52 Million - $3.23 Million	-94,073 Reduced 31.05%	208,912 $6.83 Million
Q1 2018 May 14, 2018	SELL	$25.2 - $28.54 $3.09 Million - $3.5 Million	-122,610 Reduced 28.81%	302,985 $8.28 Million
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $9.26 Million - $11.1 Million	373,605 Added 718.61%	425,595 $10.6 Million
Q3 2017 Nov 13, 2017	SELL	$26.26 - $29.17 $95,455 - $106,032	-3,635 Reduced 6.53%	51,990 $1.51 Million
Q2 2017 Aug 11, 2017	BUY	N/A	55,625	55,625 $1.54 Million

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.

Account

Banco Santander, S.A. Boston Scientific Corp Transaction History